Serum Levels of Soluble Urokinase Plasminogen Activator Receptor in Infants with Late‐onset Sepsis - Concepedia

Concepedia

Publication | Closed Access

Serum Levels of Soluble Urokinase Plasminogen Activator Receptor in Infants with Late‐onset Sepsis

16

Citations

23

References

2014

Year

Emel Okulu, Saadet Arsan, İlke Mungan Akın, Can Ateş, Serdar Alan, Begüm Atasay

Journal of Clinical Laboratory Analysis

Abstract

This is the first study that investigated the levels of suPAR in neonates and our results demonstrate that suPAR is a powerful marker of inflammation in infants with sepsis.

References

	Year	Citations
Late-Onset Sepsis in Very Low Birth Weight Neonates: The Experience of the NICHD Neonatal Research Network Barbara J. Stoll, Nellie I. Hansen, Avroy A. Fanaroff, PEDIATRICS	2002	2.3K
Neurodevelopmental and Growth Impairment Among Extremely Low-Birth-Weight Infants With Neonatal Infection Barbara J. Stoll JAMA	2004	1.5K
Effects of Melatonin Treatment in Septic Newborns Eloisa Gitto, R.J. Reiter, Dun Xian Tan, Pediatric Research Neonatal ResuscitationSleepNeonatologyMelatonin TreatmentPediatrics	2001	505
suPAR: The Molecular Crystal Ball Maria Thunø, Betina Macho, Jesper Eugen‐Olsen Disease Markers InflammationCytokineCrystal StructureSupar FragmentsSignal Transduction	2009	457
Very Low Birth Weight Preterm Infants With Early Onset Neonatal Sepsis Barbara J. Stoll, Nellie I. Hansen, Rosemary D. Higgins, The Pediatric Infectious Disease Journal Predominant PathogensPerinatal HealthNeonatologyBlood CultureBacterial Pathogens	2005	336
Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study Ove Andersen, Gitte Kronborg, Michael Tvede, Critical Care	2007	302
Plasma Urokinase Receptor Levels in Patients With Colorectal Cancer: Relationship to Prognosis Ross W. Stephens JNCI Journal of the National Cancer Institute	1999	280
Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients Alexander Koch, Sebastian Voigt, Carsten Kruschinski, Critical Care	2011	278
Serum level of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus infection Nicolai Sidénius, Cornelis F.M. Sier, Henrik Ullum, Blood	2000	200
The level of urokinase-type plasminogen activator receptor is increased in serum of ovarian cancer patients. Cornelis F.M. Sier, Ross W. Stephens, Jozef Bízik, PubMed Tumoral PathologySerum Soluble UparEndocrine-related CancerMedicinePathology	1998	192

Page 1